Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Purpleman who wrote (10080)	2/26/1999 1:21:00 AM
From: Coz	Read Replies (2) \| Respond to of 56532

Purpleman : ASCT -- I feel what happened to the price is there were a lot of traders in this for the buyout, but when the deal came, it wasn't what we were expecting. I think since then that the traders have been selling their shares, and there are not sufficient new buyers stepping in to support the price. Hence the price drops to attract buying interest. I'm not sure what part the shorters have had in wrecking the price. What I expect needs to happen is the stock will need to attract value investors who are looking at the long term picture. Perhaps when one or both of the new drugs are approved this will happen. The drugs could be approved as early as April, but when I talked with management, they cautiously said sometime this year. --Coz